Announce Date | 05/07/2025 |
EPS Normalized Actual | $-0.24 (Miss by $-0.03) |
EPS GAAP Actual | $-0.24 (Miss by $-0.03) |
Revenue Actual | $0.431618B |
Revenue Surprise | Beat by $431.618M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2029 | 0 | INF | 0 | 0 | 1 |
Sep 2027 | 2.2 | 3.4 | 1.88584 | 2.34 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.24 | -0.24 | 0.431618B | -44.37% | 431.62M |
FQ4 2024 (Dec 2024) | -0.32 | -0.32 | 0.186788B | -94.85% | 186.79M |
FQ3 2024 (Sep 2024) | 0.37 | 0.37 | 1.22815B | 45.2% | 1228.15M |
FQ2 2024 (Jun 2024) | 0.0061 | 0.0061 | 0.483317B | -10.97% | 483.32M |
FQ1 2024 (Mar 2024) | -0.0723 | -0.0723 | 0.623141B | -12.04% | 623.14M |
FQ4 2023 (Dec 2023) | 0.141173 | 0.141173 | 0.363956B | 14.7% | 363.96M |
FQ3 2023 (Sep 2023) | 0 | 0 | 0.672982B | 100% | 672.98M |
FQ2 2023 (Jun 2023) | -0.0002 | -0.0002 | 0.536351B | 100% | 536.35M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2029 (Jun 2029) | 0 | -- | 0 | 0 | 2 |
FQ1 2029 (Mar 2029) | 0 | -- | 0 | 0 | 2 |
FQ4 2028 (Dec 2028) | 0 | -- | 0 | 0 | 3 |
FQ3 2028 (Sep 2028) | 0 | -- | 0 | 0 | 5 |
FQ2 2028 (Jun 2028) | 0 | -- | 0 | 0 | 5 |
FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 5 |
FQ4 2027 (Oct 2027) | 0.5899 | -- | 0.5899 | 0.5899 | 7 |
FQ3 2027 (Jul 2027) | 0.4645 | -- | 0.4645 | 0.4645 | 6 |
FQ2 2027 (Jun 2027) | 0.4645 | -- | 0.24837 | 0.55053 | 6 |
FQ1 2027 (Mar 2027) | 0.3501 | -- | 0.1872 | 0.41494 | 8 |
FQ4 2026 (Dec 2026) | 0.2189 | -- | 0.2189 | 0.2189 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2029 (Jun 2029) | 2.54B | -- | 2.07B | 3.46B | 9 |
FQ1 2029 (Mar 2029) | 1.83B | -- | 1.48B | 2.48B | 9 |
FQ4 2028 (Dec 2028) | 0.63B | -- | 0.51B | 0.85B | 8 |
FQ3 2028 (Sep 2028) | 1.35B | -- | 1.06B | 2B | 8 |
FQ2 2028 (Jun 2028) | 2.43B | -- | 1.91B | 3.61B | 5 |
FQ1 2028 (Mar 2028) | 1.74B | -- | 1.37B | 2.59B | 4 |
FQ4 2027 (Oct 2027) | 1.52B | -- | 1.52B | 1.52B | 8 |
FQ3 2027 (Jul 2027) | 1.3B | -- | 1.3B | 1.3B | 7 |
FQ2 2027 (Jun 2027) | 1.3B | -- | 0.84B | 1.49B | 7 |
FQ1 2027 (Mar 2027) | 1.15B | -- | 0.74B | 1.32B | 9 |
FQ4 2026 (Dec 2026) | 0.95B | -- | 0.95B | 0.95B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.24 | -0.24 | 100% | |
FQ4 2024 (Dec 2024) | -0.32 | -0.32 | 100% | |
FQ3 2024 (Sep 2024) | 0.37 | 0.37 | 100% | |
FQ2 2024 (Jun 2024) | 0.0061 | 0.0061 | 100% | |
FQ1 2024 (Mar 2024) | -0.0723 | -0.0723 | 100% | |
FQ4 2023 (Dec 2023) | 0.141173 | 0.141173 | 100% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Jun 2023) | -0.0002 | -0.0002 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.43B | $431.62M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.19B | $186.79M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.23B | $1228.15M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.48B | $483.32M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.62B | $623.14M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.36B | $363.96M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.67B | $672.98M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.54B | $536.35M | 100% |